2016-12-10T00-22-31Z
Source: Indo American Journal of Pharmaceutical Research
Karuna M*, Ravindra Babu S.
Caesalpinia digyna rottler is used in the treatment of hypertension, inflammation, diabetes, hepatotoxicity. In the present study methanolic extract of Caesalpinia digyna Rottler root (MECD) at doses of 200 and 400 mg/kg was evaluated on N-nitro-L-arginine methyl ester (L-NAME) induced hypertensive rats by observing blood pressure and heart rate. The anti hypertensive activity of the MECD were studied using a non-invasive rat tail-cuff blood pressure system.The MECD produced significant decrease (p
http://ift.tt/2h8EQA8
Σάββατο 10 Δεκεμβρίου 2016
ANTIHYPERTENSIVE AND ANTIOXIDANT ACTIVITY OF CAESALPINIA DIGYNA ROTTLER IN L-NAME INDUCED HYPERTENSIVE RATS
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
Background Hyperthyroidism is associated with increased thrombotic risk. As contact system activation through formation of neutrophil extrac...
-
UM-Chor1: establishment and characterization of the first validated clival chordoma cell line. J Neurosurg. 2017 Apr 21;:1-9 Authors:...
-
Publication date: Available online 10 May 2017 Source: Journal of Dairy Science Author(s): R.E. Vibart, M. Tavendale, D. Otter, B.H. Schw...
-
Competency-based psychiatric education for Indian medical undergraduates Vijayalakshmi Pernenkil Archives of Mental Health 2019 20(1):1-2 Be...
-
Related Articles Developmental control of macrophage function. Curr Opin Immunol. 2017 Dec 13;50:64-74 Authors: Bonnardel J, Guillia...
-
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2tcPIjn via IFTTT
-
Abstract: Epidermolytic ichthyosis (EI) is a rare disorder of cornification caused by mutations in KRT1 and KRT10, encoding two suprabasal e...
-
Bloomberg Celgene Settles Whistle-Blower Fraud Suit for $280 Million Bloomberg Even after the FDA approved Thalomid for multiple myelo...
-
Related Articles Chinese version of the Constant-Murley questionnaire for shoulder pain and disability: a reliability and validation ...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου